Trial Details
TERMINATEDBasic Information
| Clinical ID | c3066 |
|---|---|
| Identifier | NCT02566889 |
| Trial Title | An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Inflammatory Bowel Diseases |
| Interventions | DRUG: Infliximab |
Participant Information
| Sponsor | Janssen Scientific Affairs, LLC |
|---|---|
| City | Phoenix |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2016-04 |
|---|---|
| Primary Completion Date | 2019-07 |
| Completion Date | 2019-07 |